StockData
Medline Inc. logo

Medline Inc. (MDLN) income statement

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3068% above fair value
$37.84−1.32 (-3.37%)

Close on Nov 19, 2026Market cap $49.75BP/E –Yield –

Medline Inc. income statement

Ratios

Latest available, balances at Sep 26, 2026

Profitability, TTM

Gross margin
25.7%
Operating margin
5.7%
Net margin
3.8%
Return on equity, FY2025
–

Financial strength

Current ratio
4.04
Debt to equity
1.07
Debt to assets
31.3%
Cash to current liabilities
74.2%

Valuation

P/E ratio
–
Price to sales
1.62
Price to book
4.22
Dividend yield
–

See a number that looks wrong?